NCT03470467

Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 300 (estimated)
• Sponsor: Ictal Group · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Posterior Reversible Encephalopathy Syndrome prospective (PRES) registry. Data collection using a standardized form : demographic data and data related to the PRES, including circumstances of onset, dates and times of onset and of symptoms control, on-scene clinical findings, clinical and radiological features of PRES, pre-hospital and hospital care providers, timing of antiepileptic, antihypertensive drugs and supportive treatments, results of etiological investigations, cause of PRES, type and dosage of antiepileptic and antihypertensive drugs. Dates and times of EEG monitoring, EEG results, radiological and biological investigations. Outcomes including vital status and Glasgow Outcome Scale score at ICU and hospital discharge, day-90 and 1-year after SE and determined based on data in the ICU and/or neurologist charts and/or patients phone interview

Conditions

• Posterior Reversible Encephalopathy Syndrome

Interventions

Type	Name	Description
OTHER	No intervention	No intervention planed

Timeline

• Start date: 2018-03-09
• Primary completion: 2028-12-31
• Completion: 2028-12-31
• First posted: 2018-03-20
• Last updated: 2019-08-08

Locations

1 site across 1 country: France